The 2024 Canadian semaglutide market generated $1.18 billion in revenue, and is expected to surpass $4 billion by 2035, according to market research firm Grand View Research.
Patients should be educated on recognising and managing hypoglycaemia, and dose adjustments of concomitant medications may be necessary
If you develop severe pain, persistent swelling, signs of infection (warmth, pus, fever), or severe nausea that interferes with eating, contact your PlexusDx provider immediately
In Phase II detoxification, glutathione S-transferase enzymes conjugate GSH to electrophilic xenobiotics and endogenous metabolites, facilitating their excretion
Enhanced Recovery : Ingredients like BPC-157 and Ac-SDKP support faster muscle recovery